Thursday, 20 June 2019

Drug Discovery News

  • Glenmark receives two ANDA approvals from the FDA

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Mar, 2016

    Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administration (US FDA) for Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0...Read more

  • Researchers working on new drug for Lupus

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 Jul, 2012

    Singapore: It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year old, Benlysta (belimumab) is the first human monoclonal antibody for t...Read more

  • Stem cell therapy effective in liver cirrhosis

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2012

    Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chinese hospitals, documents the effectiveness of cord blood-derived stem c...Read more

  • Old drug gives hope for new treatment in autism

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of California, San Diego School of Medicine, have used a newly discovered fun...Read more

  • Boehringer, Swiss institute collaborate on diabetes and obesity research

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Sep, 2012

    Singapore: Boehringer Ingelheim and the Institute of Molecular Health Science and the Institute of Food, Nutrition and Health of ETH Zurich entered into a four-year, industry-academia colla...Read more

  • Omega-3 can reduce brain problems after stroke

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

    Singapore: A new study by researchers at Columbia University Medical Center, US, revealed that injection of triglyceride lipid emulsions (that are rich in an omega-3 fatty acid) within a fe...Read more

  • KHK advances DsiRNA cancer target, pays $5 mn

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2013

    Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology therapeutics, announced that Kyowa Hakko Kirin (KHK) has elected to advanc...Read more

  • Celgene halts phase III trial of cancer drug Revlimid

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open-label, phase III ORIGIN trial, which enrolled 450 patients in over 1...Read more

  • BMS seeks Hep C therapy approval in Japan

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency seeking the world's first interferon-free and ribavirin-free ...Read more

  • Daiichi US appoints Glenn Gormley as chairman

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

    Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US. Dr Gormley will also continue in his existing roles as president, Daiichi Sankyo ...Read more

  • Singapore nod for BMS, Pfizer heart drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Nov, 2013

    Singapore: Health Sciences Authority (HSA) in Singapore has approved new treatment, apixaban (Eliquis), marketed by pharmaceutical companies Pfizer and Bristol-Myers Squibb (BMS), to reduce...Read more

  • Aus firm to raise $10 mn for multiple sclerosis drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2013

    Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12) million through an IPO of up to 60 million shares at $0.18 (A$0.20)...Read more

  • WuXi PharmaTech partners with Pharmacyclics

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2013

    Singapore: Shanghai SynTheAll (STA) Pharmaceutical, subsidiary of WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company wi...Read more

  • BHR expands brain injury treatment trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

    Singapore: BHR Pharma has started recruiting patients, who are suffering from severe traumatic brain injury (TBI), for their SyNAPSe clinical trial at 14 sites in Thailand, China and Russia...Read more

  • Astellas, Ambit Biosciences begin quizartinib trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Singapore: Japan-headquartered Astellas Pharma and Ambit Biosciences have initiated the phase IIb open-label clinical trial of quizartinib as monotherapy in patients with relapsed and refra...Read more

  • Next-Generation Pipetting

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Sample preparation is a daily function in any life science research or drug discovery lab and pipetting is a fundamental step in this process. Almost every experiment requires the transfer ...Read more

  • Bayer stops haemophilia trial amidst drug safety concern

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 May, 2013

    Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain haemophilia A and B patients due to safety concerns. A spokesperson...Read more

  • Boehringer seeks EU marketing nod for cancer drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2013

    Singapore: Boehringer Ingelheim has submitted a marketing authorization application to the European Medicines Agency (EMA) for the approval of its oral triple angiokinase inhibitor nintedan...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls